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MMPPhenotypic modulation of endothelium to a dysfunctional state contributes to the pathogenesis of
atherosclerosis, partly through the activation of the transcription factor NFkB. Several data indicate that
magnesium deﬁciency caused by prolonged insufﬁcient intake and/or defects in its homeostasis may be a
missing link between diverse cardiovascular risk factors and atherosclerosis. Here we report that endothelial
cells cultured in low magnesium rapidly activate NFkB, an event which is prevented by exposure to the anti-
oxidant trolox. It is well known that NFkB activation correlates with marked alterations of the cytokine
network. In the present study, we show that exposure of endothelial cells to low magnesium increases the
secretion of RANTES, interleukin 8 and platelet derived growth factor BB, all important players in
atherogenesis. Moreover, we describe the increased secretion of matrix metalloprotease-2 and -9 and of
their inhibitor TIMP-2. Interestingly, by zymography we show that metalloprotease activity predominated
over the inhibitory effect of TIMP-2.
These results indicate that low magnesium promotes endothelial dysfunction by inducing pro-inﬂammatory
and pro-atherogenic events.protease, MMP; inhibitor of
acrophage-colony stimulating
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Vascular endothelium, which comprises a monolayer of more than
ten trillion endothelial cells, represents a dynamic interface between
the blood and the surrounding tissues [1]. Apart from forming a
selective semi-permeable barrier, the endothelial cells actively and
reactively control vascular tone and hemostasis as well as the ingress
and egress of leukocytes. Consequently, it is not surprising that
endothelial dysfunction is the common denominator that links
cardiovascular risk factors and some diseases (diabetes, hyperlipemia,
and hypertension) to atherosclerotic burden [2]. Indeed, endothelial
dysfunction contributes to the initiation and progression of athero-
sclerotic disease and has been suggested to be an independent
vascular risk factor [3].
Also magnesium (Mg) deﬁciency has been reported to be
involved in the pathogenesis of cardiovascular diseases in general
and of atherosclerosis in particular [4]. Indeed, Mg fortiﬁcation ofdrinking water succeeded in the inhibition of atherogenesis in APO-
E-deﬁcient mice fed with a high cholesterol diet [5] and oral Mg
therapy has been associated with signiﬁcant improvement of
endothelial function in patients with coronary artery disease
(CAD) [6]. In addition, the Atherosclerosis Risk in Communities
Study concluded that the highest risk for CAD occurred in subjects
with the lowest serum Mg, even after controlling for the traditional
CAD risk factors [7]. Evidence suggests that the occidental diet is
relatively deﬁcient in Mg because of preference for calorie-rich,
micronutrient-poor foods, low Mg content in water and soil, and
processing of many food items [8]. Moreover, it should be recalled
that Mg deﬁciency is a signiﬁcant clinical complication arising in
patients with diabetes mellitus, in nephropathics, in individuals
treated with some classes of diuretics or anticancer drugs, as well as
in alcoholists. Hypomagnesemia is also common in hospitalized
patients, in particular in the elderly [8].
In cultured endothelial cells, low Mg increases the adhesion of
monocytes to cultured endothelial cells via the upregulation of
Vascular Cell Adhesion Molecule (VCAM), induces plasminogen
activator inhibitor (PAI) 1, augments the levels of the pro-inﬂamma-
tory cytokine interleukin (IL)-1 alpha, impairs endothelial prolifera-
tion and promotes cellular senescence [9,10]. Recently, endothelial
function has been shown signiﬁcantly impaired in a model of
inherited hypomagnesemia in mice (MgL mice) [11]. In agreement
with the results obtained in cultured endothelial cells, MgL aortas had
higher expression of VCAM and PAI-1 than their controls [11]. In
addition, in Mg deﬁcient rodents an inﬂammatory response has been
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the acquisition of an inﬂammatory phenotype in the endothelium.
The family of transcription factors named NFkB controls the global
inﬂammatory response and regulates the pro-atherogenic program in
endothelial cells [13]. In resting cells, NFkB subunits are held in the
cytosol because of their association with inhibitory proteins denomi-
nated IkB [13]. Upon cytokine signalling or environmental stress,
NFkB activation is initiated [14]. The canonical pathway of NFkB
activation involves the rapid degradation of IkB by the proteasome,
the release of NFkB subunits, their translocation to the nucleus and
binding to the cognate DNA motifs in target genes.
Because i) endothelial dysfunction, early event in atherogenesis, is
driven by NFkB [14], and ii) Mg deﬁciency affects endothelial
behaviour and contributes to atherosclerosis [4,9], we investigated
NFkB in human umbilical vein endothelial cells (HUVEC) cultured in
low Mg. We show that Mg deﬁciency activates NFkB and this event
associates with the overexpression of the chemokines IL-8 and
RANTES, of platelet derived growth factor (PDGF)-BB, Tissue Inhibitor
of Matrix Metalloproteases (TIMP)-2 and metalloproteases (MMP) 2
and 9, all implicated in inﬂammation and atherogenesis.
2. Materials and methods
2.1. Cell culture and reporter gene assay
Human umbilical vein endothelial cells (HUVEC) were cultured in
M199 containing 10% fetal bovine serum, 1 mM glutamine, 1 mM
penicillin and streptomycin, Endothelial Cell Growth Factor (ECGF,
150 μg/mL), 1 mM sodium pyruvate and heparin (5 U/mL) on 2%
gelatin-coated dishes [9]. A magnesium free medium was purchased
by Invitrogen (San Giuliano M.se, Italy) and utilized to vary the
concentrations of magnesium by the addition of MgSO4 [9]. On the
basis of previous reports [9], we cultured HUVEC in medium
containing 0.1 or 1.0 mM. In all the experiments the cells were
seeded in growth medium; after 24 h, the medium was changed to
expose the cells to either 0.1 or 1.0 mM Mg. In some experiments
HUVEC were exposed to lipopolysaccharide (LPS) (1 μg/mL) or trolox
(40 μM) (all from Sigma Aldrich, St Louis, MO). Dose response
experiments with trolox indicated that in our cells 40 μM is the lowest
concentration reproducibly yielding an effect. HUVECwere pretreated
with trolox for 1 h and then maintained in the presence of trolox for
the duration of the experiment.
For reporter gene assays, subconﬂuent HUVEC were transfected
with a luciferase reporter plasmid (0.2 μg/cm2) containing multiple
copies of the NFkB consensus (pGL4.32[luc2P/NFkB-RE/Hygro]vector,
Promega Italia, Milano, Italy) using Arrest-in (Invitrogen). Cells were
cotransfected with the pRL-TK-TK plasmid encoding Renilla luciferase
(5 ng/cm2), as a control for differences in transfection efﬁciency. After
4 h, the cells were exposed overnight to either in 0.1 or 1.0 mM Mg.
Fireﬂy and Renilla luciferase activities were measured using the Dual-
Luciferase Reporter Assay System (Promega Italia, Milano, Italy),
according to the manufacturer's instruction. Fireﬂy luciferase activity
was normalized to Renilla luciferase activity. Results are shown as the
mean±standard deviation (SD) of three separate experiments in
triplicate.
2.2. Electrophoretic mobility shift assays (EMSA)
Nuclear extracts were prepared and protein concentration was
determined with Bradford reagent (Sigma Aldrich). Single strand
oligonucleotide with consensus binding-sites of NFkB (5′-GATCCTCAA-
CAGAGGGGACTTTCCGAGGCCA-3′) was labelledwith T4 polynucleotide
kinase (GE Healthcare, Milano, Italy) by using 32P-ATP, annealed to the
complementary strand (5′-TGGCCTCGGAAAGTCCCCTCTGTTGAG-
GATCC-3′), and then puriﬁed by polyacrylamide gel electrophoresis.
5 μg of nuclear extract was incubated for 30 min at roomtemperature with 20 kcpm of 32P-labelled probe in binding buffer
(50 mM NaCl, 10 mM Tris–HCl pH 7.8, 1 mM EDTA, 5% glycerol,
0.5 mM DTT). All binding reactions contained 0.5 μg poly (dI·dC)
as a nonspeciﬁc competitor. For competition experiments, 50-fold
excess of unlabelled speciﬁc or unrelated double-stranded
sequences was added to the binding mixtures. For supershift
experiments, nuclear extracts were incubated with antibodies
(1 μg) against p65 and p50 (Santa Cruz Biotechnology-Tebu Bio,
Magenta, Italy) for 60 min on ice followed by 25 min of incubation
with oligonucleotide.
Protein–DNA complexes were resolved on 5% acrylamide gels. Gels
were dried and radiolabelled bands detected by autoradiography. The
experiments were repeated three times with similar results.
2.3. Protein array
HUVEC were cultured in medium containing 0.1 or 1.0 mMMg for
2 days. 5 mL of conditioned media was centrifuged and utilized to
incubate the membranes on which 40 antibodies against cytokines
were spotted in duplicate (RayBiotech-Tebu Bio, Milano, Italy). The
assay was performed according to the manufacturer's instructions.
Densitometry was performed by the ImageJ software. Data are
expressed as the mean±SD of two separate experiments in duplicate.
2.4. TransAM assay
TransAM assays were performed according to the manufacturer's
instructions (ActiveMotif, Carlsbad, CA, USA). TransAMNFkB family kits
are ELISA-based kits designed speciﬁcally to quantify NFkB activation. In
brief, 5 μg of nuclear protein samples was incubated for 1 h in a 96-well
plate coated with an oligonucleotide that contains the NFkB consensus
site (5′-GGGACTTTCC-3′) to which activated NFkB factors contained in
nuclear extracts speciﬁcally bind. By using an antibody directed against
an epitope on p50 or p65 that is accessible only when NFkB is activated
and bound to its target DNA, the NFkB complex bound to the
oligonucleotide is detected. After incubation for 1 h with a secondary
horseradish peroxidase-conjugated antibody, speciﬁc binding was
detected by colorimetric estimation on a spectrophotometer at
450 nm. Results are expressed as arbitrary units and represent the
mean±SD of two separate experiments in triplicate.
2.5. Immunoblot analysis and ELISA
Culture media were resolved by SDS-PAGE, transferred to
nitrocellulose sheets at 200 mA for 16 h, and probed with anti-
PDGF-BB, anti-RANTES, anti-IL-6, anti-MMP-9 and anti-MMP-2 anti-
bodies (Santa Cruz Biotechnology-Tebu Bio). Secondary antibodies
were labelled with horseradish peroxidase (GE Healthcare). The
SuperSignal chemiluminescence kit (Pierce, Rockford, IL) was used to
detect immunoreactive proteins. In some experiments, nuclear
extracts were obtained using the Nuclear Extract kit (Active Motif)
and processed by western blot using antibodies against NFkB subunit
p50 or p65 (Tebu Bio). All the experiments were repeated at least
three times with comparable results.
The amounts of TIMP-2 and IL-8 were measured in 1:2 diluted
medium using a double-antibody sandwich ELISA (GE Healthcare)
according to the manufacturer's instructions. The concentrations of
TIMP-2 and IL-8 were determined by interpolation from a standard
curve and shown as the mean±SD of four separate experiments in
triplicate.
2.6. Gelatin zymography
Conditioned media were incubated at 4 °C overnight with
gelatin–Sepharose. Zymography was performed using 8% poly-
acrylamide gels co-polymerized with 1 mg/mL gelatin type B
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Gels were then washed twice for 30 min in 2.5% Triton X-100 at
room temperature and incubated overnight in collagenase buffer
(50 mmol/L Tris–HCl, pH 7.5, 10 mmol/L CaCl2, 150 mmol/L NaCl)
at 37 °C. Gels were stained in Coomassie Blue R 250 (Bio-Rad,
Milano, Italy) in a mixture of methanol:acetic acid:water (4:1:5)
for 1 h and destained in the same solution without the dye.
Gelatinase activities were visualized as distinct bands.
2.7. Statistical analysis
Statistical signiﬁcance was determined using the Student's T test
and set at p values less than 0.05. In the ﬁgures *: pb0.05; **: pb0.01;
***: pb0.001.
3. Results
3.1. Activation of NFkB in Mg deﬁcient HUVEC
Because i) Mg deﬁciency promotes inﬂammation and atherogenesis
[4,12] and ii) NFkB regulates many genes involved in inﬂammation and
atherosclerosis [13,14], we examined the effects of low Mg on NFkB
activation.We ﬁrst performed EMSA on nuclear extracts prepared from
HUVEC cultured in 1.0 or 0.1 mM Mg for 1 h. In nuclear extracts of
HUVEC in 1.0 mM Mg, no retarded band was detected whereas two
distinct bands could be clearly shown in the samples from cells exposed
to 0.1 mM Mg (Fig. 1A, left panel). It is noteworthy that these bands
were markedly induced by treatment with LPS (1 μg/mL), which isFig. 1. Induction of NFkB activity in HUVEC cultured in low Mg. (A) EMSA of the NFkB DN
1.0 mMMg for 1 h, in the presence or in the absence of LPS (left panel). SP and UN are the
Mg. The binding activity of the constitutively expressed transcription factor oct-1 was use
densitometry and expressed on an arbitrary scale. (B) HUVEC were exposed to LPS for 1 h.
electrophoresed. The shifting of the different NFkB subunits is indicated by white arrowh
Mg in the presence or in the absence of LPS were analyzed by western blot using antibodie
contamination by cytosol. (D) Luciferase assay was performed in HUVEC cultured in 0.1 or
ﬂuorimetry. Results are shown as the mean±SD of three separate experiments.used as a positive control, in HUVEC in 0.1 and in 1.0 mM Mg. On the
basis of the supershift analysis (Fig. 1B), these two bands were
identiﬁed as the p50/p50 homodimer and p50/p65 heterodimer.
Interestingly, in the presence of LPS a third shifted band – by
supershift identiﬁed as the homodimer p65/65 – was detected. All
the bands were speciﬁc as assessed by competition assays showing
their suppression by incubation with a 50-fold excess of unlabelled
NFkB probe (Fig. 1A, left panel). The bands revealed by EMSA were
quantiﬁed by densitometry (Fig. 1A, right panel).
The localizationof p50andp65,which areknown to translocate to the
nucleus upon activation, was then assessed by western blot. We found
that both p50 and p65 accumulate in the nuclei within 1 h of culture in
0.1 mM Mg (Fig. 1C) and that LPS markedly induced the nuclear
translocation of the two proteins in HUVEC in 0.1 and in 1.0 mMMg.
The increase of NFkB binding activity by Mg deﬁciency correlated
with the functional induction of NFkB as demonstrated by reporter
gene assays using a vector expressing luciferase under the control of
multiple copies of the NFkB responsive consensus. The construct was
transiently transfected into HUVEC and the activity of luciferase was
monitored as described in Materials and methods. An increase of
luciferase activity was observed in cells exposed to 0.1 mM Mg both
under basal conditions and after exposure to LPS, indicating that the
NFkB complexes are transcriptionally active (Fig. 1D).
3.2. Inhibition of NFkB activation by trolox in Mg deﬁcient HUVEC
Mg deﬁciency has been associated with oxidative stress [15]
which is known to activate NFkB [14]. We therefore evaluatedA binding activity was performed on nuclear extracts from HUVEC cultured in 0.1 or
speciﬁc and unspeciﬁc competition, respectively, of the LPS-treated HUVEC in 1.0 mM
d to assess equal loading. Right panel: each band detected by EMSA was quantiﬁed by
Nuclear extracts were incubated with 1 μg of anti-p65 or anti-p50 antibodies and then
eads. (C) Nuclear extracts from HUVEC cultured in medium containing 0.1 or 1.0 mM
s against p65 or p50. TBP was used as a nuclear marker and GAPDH as an indicator of
1.0 mMMg as described in Materials andmethods. Luciferase activity was detected by
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cultured in low Mg. Among many anti-oxidants available, for these
studies we selected trolox, a water-soluble analog of α-tocopherol
which has been demonstrated to exert a more potent cytoprotective
effect than α-tocopherol [16]. HUVEC were pretreated with trolox
(40 μM) for 60 min before being exposed to 0.1 mM Mg containing
medium for 1 h.
We ﬁrst evaluated nuclear translocation of p65 and p50 in HUVEC
cultured in 0.1 or 1.0 mM Mg in the presence or in the absence of
trolox. We found that trolox inhibited p65 and p50 nuclear
accumulation (Fig. 2A). Quantiﬁcation through the TransAM assay
conﬁrmed this ﬁnding for both p50 and p65 (Fig. 2B).
These results strongly suggest that NFkB activation by Mg
deﬁciency is mediated by oxidant species.Fig. 2. Inhibition of low Mg-induced NFkB activation by trolox. (A) Nuclear extracts of
HUVEC in 0.1 or 1.0 mM Mg in the presence or in the absence of trolox (40 μM) for 1 h
were obtained. Western blot was performed with antibodies against p65 or p50. TBP is
shown as loading and fraction purity control. GAPDH shows that cytosolic contami-
nation is very low. (B) p65 and p50 activity was quantiﬁed by TransAM NFkB analysis
on nuclear extracts of HUVEC cultured in 0.1 or 1.0 mM Mg with or without trolox.
Results are expressed as arbitrary units and represent the mean±SD of 3 separate
experiments.3.3. Modulation of molecules involved in atherogenesis and
inﬂammation in Mg deﬁcient HUVEC
We utilized a protein array tailored for proteins involved in
inﬂammation and atherogenesis to study how culture of HUVEC in
low Mg modulated the levels of these molecules. To this purpose,
HUVEC were cultured for 48 h in 0.1 or 1.0 mMMg. The medium was
then collected and utilized for the proteomic analysis. The results
were quantiﬁed by densitometry. Fig. 3 shows a signiﬁcant increase of
the secretion of PDGF-BB, TIMP-2 and IL-8, and to a lower extent, of
granulocyte macrophage-colony stimulating factor (GM-CSF) and
RANTES in HUVEC in 0.1 mM Mg. No modulation of secreted
transforming growth factor β1, IL-6 and tumor necrosis factor (TNF)
α was detected. On the basis of their relevance in atherosclerosis,
some of these proteins were further investigated by western blot or
ELISA. Western blot conﬁrms that, while IL-6 is not altered, secreted
PDGF-BB and RANTES are increased in Mg deﬁcient HUVEC (Fig. 4, left
panel). Fig. 4 (right panel) also shows the results of the densitometric
analysis. We then measured the levels of IL-8 and TIMP-2 by ELISA.
Fig. 5A and B show the increase of the two secreted proteins in Mg
deﬁcient HUVEC vs controls.
3.4. MMP activity in Mg deﬁcient HUVEC
Because TIMP-2 antagonizes the action of MMP-2 and -9 [17], we
evaluated the effect of Mg deﬁciency on the expression and on the
activity of these proteases. By western blot we found that HUVEC in
0.1 mM Mg secreted higher amounts of the gelatinases MMP-9 and
MMP-2 in respect to the controls (Fig. 6A).We then analyzed medium
collected from HUVEC cultured for 48 h in 0.1 or 1.0 mM Mg by
zymography. Two clear bands of gelatinolytic activity, sized to 88 and
68 kDa, corresponding to activated MMP-9 and -2 respectively, were
detected. Fig. 6B shows the higher gelatinolytic activity of MMP-2 and
-9 in the medium from cell cultured in 0.1 mM vs 1.0 mM Mg.
4. Discussion
Mg is the fourth most abundant cation in the human body.
Approximately 60–65% of the total body Mg is mineralized in bone,
whereas the remaining part is mainly localized in the intracellular
compartments and only 1% is circulating in the blood. Current dietary
guidelines recommend adequate intake of Mg (310–420 mg daily) to
maintain a proper serum Mg concentration without drastically
depleting theMg stores. Hypomagnesaemia (serumMg concentration
below 0.74 mmol/L, or 1.8 mg/dL) can be the result of some
therapeutic regimens and of various pathological conditions, includ-
ing hereditary diseases [8,18–20]. In rodents, serumMg concentration
drops to 0.1 mM after 8 days on a Mg deﬁcient diet. This is the
concentration of extracellular Mg we used in our experimental model
because it allows to detect signiﬁcant effects in vitro. It should be
pointed out, however, that we previously observed endothelialFig. 3. Protein arrays on media collected from HUVEC cultured in 0.1 or 1.0 mM Mg for
48 h. Densitometric analysis on array spots was performed and data are expressed as
the mean±SD of two separate experiments.
Fig. 4. Amounts of secreted RANTES, PDGF-BB and IL-6 in Mg deﬁcient HUVEC. A representative western blot on conditioned media from HUVEC cultured in 0.1 or 1.0 mM Mg is
shown (left panel). Densitometric analysis was performed and data are expressed as the mean±SD of three separate experiments (right panel).
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[9]. On the other hand, it is possible that locally restricted dramatic
changes in Mg concentration occur and inﬂuence endothelial cells in a
speciﬁc district.
Mg is essential to maintain health and lower the risk of
cardiovascular disease. Recent evidence from animal and clinical
studies suggests that low Mg is associated with inﬂammatory
processes and atherogenesis [21]. Being endothelial dysfunction a
critical step in atherogenesis, it is noteworthy that low Mg induces
IL-1, VCAM and PAI-1 and promotes a senescent phenotype in
cultured endothelial cells [9,10]. However, the molecular mechan-
isms involved have not been elucidated. We anticipated a role of
the transcription factor NFkB, crucial regulator of inﬂammation
and atherosclerosis [13,14], which is activated in experimental and
human atherosclerosis [22]. In Mg deﬁcient HUVEC NFkB is rapidlyactivated. In particular, we have analyzed the prototypical NFkB
complex demonstrating the involvement of p50 and p65 in low Mg
dependent NFkB activation. Our results are in agreement with data
obtained in primary cultured cerebral vascular smooth muscle cells
demonstrating that low extracellular Mg activates NFkB [23]. In
addition, Mg supplementation markedly attenuates NFkB nuclear
translocation and protects IkB from degradation in LPS-treated
endothelial cells [24]. Interestingly, in a model of cyclosporine-induced
nephrotoxicity in rats, Mg supplementation showed marked beneﬁcial
effects by preventing NFkB activation which is responsible for renal
damage [25]. Therefore, Mg levels seem to participate to the complex
regulation of NFkB activity in various systems. Mg deﬁciency has been
shown to induce oxidative stress in endothelial cells [15] and oxidative
stress is implicated in NFkB activation [22]. In atherogenesis, oxidative
stress mediates signalling pathways underlying vascular inﬂammation,
Fig. 5. Increased secretion of IL-8 and TIMP-2 in Mg deﬁcient HUVEC. (A) IL-8 and
(B) TIMP-2 were detected by ELISA in media collected from HUVEC cultured in 0.1
or 1.0 mM Mg. Data are expressed as the mean of 3 different experiments in
triplicate±SD.
957S. Ferrè et al. / Biochimica et Biophysica Acta 1802 (2010) 952–958starting from the initiation of fatty streak development, through lesion
progression, to plaque rupture [22]. Our results suggest that oxidant
species are implicated in NFkB activation, at least early after exposure to
low Mg containing medium. Indeed, in Mg deﬁcient HUVEC, the anti-
oxidant trolox, a synthetic cell-permeable analog of α-tocopherol,
prevents p50andp65nuclear translocation andactivation.We therefore
propose that in Mg deﬁcient HUVEC oxidative stress might activate
NFkB and, therefore, trigger NFkB signalling pathway. Accordingly, in
HUVECgrown in0.1 mMMgwehave shown theupregulationof IL-1α, a
pro-inﬂammatory cytokine target of NFkB, whichmediates some of low
Mg effects on these cells [9]. In the present study we utilized protein
array to obtain a broad proﬁle of the cytokines and growth factors
released by Mg deﬁcient HUVEC. Indeed, atherosclerotic plaque
development involves several synchronized events such as adhesion,
migration and proliferation of cells, all mediated by growth factors and
cytokines, someofwhich resulted signiﬁcantly increased inMgdeﬁcient
HUVEC. In particular, in cells cultured in low Mg we describe theFig. 6. Increased secretion of MMP-2 and -9 in Mg deﬁcient HUVEC. Representative western b
are shown.induction of RANTES, IL-8 and PDGF-BB, all targets of NFkB [22,26]. A
great attention has been focused on PDGF-BB in the origin of
atherosclerosis, because of its mitogenic and chemotactic effects on
vascular smooth muscle cells [27]. Indeed, the abnormal proliferation
and migration of these cells are major processes in the development of
vascular disease, not only in atherosclerosis but also in restenosis after
angioplasty. PDGF-BB is upregulated by pro-inﬂammatory stimuli from
the early stages of atherogenesis and PDGF-BB mRNA expression is
increased in atherosclerotic lesions [28,29].
We also show an increase of the secretion of the chemokines
RANTES and IL-8 in Mg deﬁcient HUVEC. Interestingly, chemokines
are important actors in the progression of atherosclerosis as well as in
plaque destabilization [30]. In particular, the enhanced expression of
IL-8 and RANTES within human atherosclerotic lesions has been
reported [22,30]. IL-8 is critical for chemotaxis and adhesion of
monocytes to the endothelial cells, pivotal steps in atherogenesis, and
also promotes vascular smooth muscle cell proliferation and migra-
tion, crucial events for the progression of the plaque [30]. Similarly,
RANTES directs leukocyte attraction and is also involved in neointima
formation in atherosclerosis-prone mice. Hence, it is not surprising
that antagonizing RANTES reduces atherosclerotic lesion formation
and stabilizes the plaque [30]. We therefore conclude that low Mg
contributes to atherosclerosis by stimulating endothelial secretion of
IL-8, RANTES and PDGF-BB. In our experimental conditions, however,
we did not observe anymodulation of TNFα and IL-6 which have been
shown increased in animal model fed with a Mg-restricted diet [12].
We hypothesize that different cell types, and not endothelial cells,
might contribute to secrete these cytokines in vivo. Protein array also
revealed the increase of GM-CSF, another cytokine which is
transcriptionally dependent upon NFkB activation. This ﬁnding is
puzzling because GM-CSF regulates intimal cell proliferation in the
early step of atherosclerosis [31]. More studies are necessary to
conﬁrm the regulation of GM-CSF levels in HUVEC cultured in lowMg.
In atherosclerotic plaques, also the expression of MMPs, which
degrade collagen ﬁbrils leading to the loss of ﬁbrous cap integrity, is
increased [22]. Dysregulated extracellular matrix metabolism has a
role in vascular remodelling during the development and complica-
tion of human atherosclerotic lesions. The expression of these
proteases is normally tightly regulated at the transcriptional level. A
second level of control is represented by the requirement of
extracellular activation of the latent pro-enzyme. A further level of
control of MMP activity involves the irreversible binding of MMPs to
the speciﬁc tissue inhibitors TIMPs. We found that Mg deﬁcient
HUVEC secreted increased amounts of MMP-2 and -9 and of their
inhibitor TIMP-2. We anticipated that the increased amounts of TIMP-lot (A) and zymography (B) on media collected from cells cultured in 0.1 or 1.0 mMMg
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However, by zymography we show that MMP-2 and -9 activity
overrides the inhibitory effect of TIMP-2. We therefore conclude that
MMP/TIMP balance is shifted toward greater MMP activity in Mg
deﬁcient HUVEC. This result further highlights how Mg deﬁciency
might contribute to atherosclerosis. Indeed, an increased expression
of MMPs in human atherosclerotic plaques and, in particular, a
marked upregulation of MMP-9 in unstable carotid plaque have been
demonstrated [32]. Recently, genetic variation within the MMP-2
promoter region was associated with cap thickness and therefore it
may inﬂuence the role of MMP-2 in plaque vulnerability [33].
5. Conclusion
Our data indicate that low Mg promotes endothelial dysfunction
by activating NFkB which, in turn, triggers a transcriptional program
leading to the acquisition of a pro-inﬂammatory and pro-atherogenic
phenotype. Based on epidemiological, cellular and molecular evi-
dence, we propose that broadly correcting nutritional intakes of Mg
might represent a simple and inexpensive solution that contributes to
the prevention of atherosclerosis.
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